Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-26 @ 9:12 AM
Study NCT ID:
NCT03810066
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2019-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)
Sponsor:
University Hospital, Essen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-10
First Submit QC Date:
None
Study First Post Date:
2019-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-07
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL